We are entering an age of at home testing and the team at Reperio just raised $14m to make weight, blood pressure and cholesterol/blood sugar testing available at home. But this is a relatively complex series of tests, intended to get people who haven’t been to a primary care doctor back into the system. How…
By MIKE MAGEE In the wake of last week’s human tragedy in Texas, it would be easy (and appropriate) to focus on the role played by Trump’s reckless recent dismantling of FEMA and related federal agencies. But to do so would be to accept that the event was an anomaly, or as Trump labeled it on…
Samsung announced plans to acquire Xealth, a startup that helps hospitals integrate digital tools into clinical workflows, as part of its broader push into U.S. healthcare. The deal reflects growing provider demand for tech solutions and comes amid newfound optimism in the digital health exit market. The post Samsung Deepens Healthcare Bet With Xealth Acquisition…
Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally formulated as a tablet, has a new dose strength and formulation designed for treating newborns and young infants who develop malarial infections. The post Novartis Drug Becomes First Malaria Therapy for Newborns and Infants appeared first on MedCity News.
Things turn out best for the people who make the best of the way things turn out. John Wooden
[Sponsored] Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors. The post The 3 Best Options to Buy Telemedicine Carts for Neurology Care appeared first on MedCity News.
The industry needs smart conversations that challenge assumptions and invite the full spectrum of voices to the table to ensure technology evolves in a way that’s not only clinically sound, but ethically aligned with what patients and providers need most. The post The Future of Surgery: Bridging Innovation and Collaboration appeared first on MedCity News.
Every day, patients are making agonizing choices to skip medications due to cost, and the fallout is evident in worsening health and avoidable hospitalizations. Health systems are in a prime position to break this cycle by acting as advocates for their patients’ financial as well as physical well-being. The post When Cost Blocks Care: Why Medication…
Demonstrating the clinical utility and cost-effectiveness of innovative blood-based biomarker tests can help pave the way for making timely AD diagnosis and proactive care the norm. The post Broadening Biomarker Validation for Alzheimer’s Disease Diagnosis Globally appeared first on MedCity News.
By TREVOR VAN MIERLO Most of us know the story of the Model T – but what’s often overlooked is how it applies to other industries, especially digital health. Let’s revisit: In the early 1900s cars were custom built. You’d meet with a consultant, design the car, place your order, and wait for months for…